Chirag V Shah
Overview
Explore the profile of Chirag V Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
795
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kendra M, Kakwani A, Uppala A, Mansukhani R, Pigott D, Soubra M, et al.
J Am Pharm Assoc (2003)
. 2022 Nov;
63(1):269-274.
PMID: 36335072
Background: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality worldwide and contributes considerably to morbidity and health care costs. In October 2014, the Centers for...
2.
Kendra M, Mansukhani R, Rudawsky N, Landry L, Reyes N, Chiu S, et al.
Lung
. 2022 Jul;
200(4):481-486.
PMID: 35796786
Purpose: Chronic obstructive pulmonary disease (COPD) is a chronic condition that leads to significant morbidity and mortality. Management of COPD hospitalizations utilizing an evidence-based care bundle can provide consistent quality...
3.
Truumees M, Kendra M, Tonzola D, Chiu S, Cerrone F, Zimmerman D, et al.
Respir Care
. 2022 Jan;
67(6):631-637.
PMID: 34987079
Background: In 2015, the Centers for Medicare and Medicaid Services limited payments to hospitals with high readmission rates for patients admitted with COPD exacerbation. Decreasing readmissions in this patient population...
4.
Pathan S, Kaplan J, Adamczyk K, Chiu S, Shah C
J Crit Care
. 2020 Nov;
62:19-24.
PMID: 33227592
Background: Dexmedetomidine (DEX) withdrawal syndrome has been reported in the pediatric population, but literature describing DEX withdrawal in critically ill adults is limited. The purpose of this study was to...
5.
Mikkelsen M, Shah C, Meyer N, Gaieski D, Lyon S, Miltiades A, et al.
Shock
. 2013 Aug;
40(5):375-81.
PMID: 23903852
Background: Acute respiratory distress syndrome (ARDS) is a serious complication of sepsis, and sepsis-associated ARDS is associated with significant morbidity and mortality. To date, no study has directly examined the...
6.
Mikkelsen M, Shah C, Scherpereel A, Lanken P, Lassalle P, Bellamy S, et al.
J Crit Care
. 2011 Oct;
27(5):522.e11-7.
PMID: 21958978
Purpose: Endocan is a proteoglycan expressed by endothelial cells in the lung that may inhibit leukocyte recruitment and thus prevent the development of acute lung injury (ALI). We tested the...
7.
Chogle A, Shah C, Murthy A
J Rheumatol
. 2011 Jun;
38(6):1218-9.
PMID: 21632691
No abstract available.
8.
Shah C, Lanken P, Russell Localio A, Gallop R, Bellamy S, Ma S, et al.
Chest
. 2010 Jun;
138(5):1054-61.
PMID: 20576730
Background: In observational studies using acute lung injury (ALI) as an outcome, a spectrum of lung injury and difficult-to-interpret chest radiographs (CXRs) may hamper efforts to uncover risk factor associations....
9.
Mikkelsen M, Gaieski D, Goyal M, Miltiades A, Munson J, Pines J, et al.
Chest
. 2010 Feb;
138(3):551-8.
PMID: 20173053
Background: Protocol-driven early goal-directed therapy (EGDT) has been shown to reduce mortality in patients with severe sepsis and septic shock in the ED. EGDT appears to be underused, even in...
10.
Christie J, Shah C, Kawut S, Mangalmurti N, Lederer D, Sonett J, et al.
Am J Respir Crit Care Med
. 2009 Aug;
180(10):1010-5.
PMID: 19661249
Rationale: The receptor for advanced glycation end products (RAGE) is an important marker of lung epithelial injury and may be associated with impaired alveolar fluid clearance. We hypothesized that patients...